Omega Therapeutics
Edit info- Founded: 2017
- Location: Cambridge, MA
- Employee range: 51-100
- Clinical stage: Clin1/Clin2
- Therapy area: Hepatocellular carcinoma (ODD)
- Drug types: ONC, HEP, OPH, LNG, DRM
- Lead product: OTX-2002
- Funding: 100-500M
omegatherapeutics.com linkedin.com job board
Business:
Gene Editing
Drug notes:
OTX-2101 Clin0 NSCLC; 6 undisclosed programs RD/Clin0 SCLC, IPF, liver regeneration, corneal regeneration, alopecia, undisclosed
About:
Omega Therapeutics is developing RNA therapeutics to reprogram the topology of genomic control. Chromatin structure plays an important role in governing gene expression, which becomes perturbed in disease. Omega is addressing aberrant gene expression by engineering programmable mRNA medicines for precision genomic control using their OMEGA Epigenetic Programming platform. Multiplexing enables the targeting of many genomic sites using Omega’s Epigenomic Controllers to regain optimal gene expression to treat or cure diseases. To develop further tools, Omega uses knowledge of the 3D-genomic organization with transcriptomics and machine learning. Currently, they have multiple programs in preclinical studies for regenerative medicine and immunology.
Jobs:
News:
Omega Therapeutics reports Q3 EPS (40c), consensus (53c)
crunchbase
Nov 9, 2023
Science/business updates
external-link
Omega Therapeutics stock hits 52-week low at $1.07 - Investing.com
googlenews
Oct 7, 2024
Science/business updates
external-link
Omega Therapeutics stock target cut, keeps Overweight on clinical updates - Investing.com
googlenews
Nov 15, 2024
Science/business updates
external-link
Tissue-specific nucleic acid delivery by mixed cationic lipid particles
crunchbase
Apr 21, 2022
Science/business updates
external-link
Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
googlenews
Nov 14, 2024
Science/business updates
external-link
'Genome-tuning' biotech Omega Therapeutics snags $85M ...
fiercebiotech.com
Dec 19, 2024
Funding-related
external-link
Shares of Flagship-founded biotech fall as CEO departs - The Business Journals
googlenews
Nov 15, 2024
New hires
external-link
Omega Therapeutics Names Kaan Certel as CEO - MarketWatch
googlenews
Nov 14, 2024
New hires
external-link
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable ...
crunchbase
May 10, 2024
Science/business updates
external-link
Novo taps another Flagship startup in search for next obesity drugs - BioPharma Dive
googlenews
May 9, 2024
Science/business updates
external-link
Omega Therapeutics Announces Publication of Epigenomic - GlobeNewswire
googlenews
Sep 17, 2024
Science/business updates
external-link
Omega Therapeutics Announces Strategic Research Collaboration with Stanford University School of Medicine - PR Newswire
googlenews
Oct 14, 2021
Science/business updates
external-link
Omega Raises $126 Million to Unlock Potential of Epigenomic Controller Candidate - BioSpace
googlenews
Mar 30, 2021
Funding-related
external-link
Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio
web
Dec 31, 2024
New hires
external-link
Novo Nordisk spends up to $1.64bn on US biotech startups
crunchbase
Jan 10, 2024
Funding-related
external-link
Lipids for delivery of therapeutic agents
crunchbase
May 19, 2023
Science/business updates
external-link
Omega Therapeutics, Inc. Reports Q1 Loss, Tops Revenue Estimates
crunchbase
May 6, 2024
Science/business updates
external-link
Omega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk - Yahoo Finance
googlenews
Jan 5, 2024
Science/business updates
external-link
Novo taps Flagship startups to develop drugs for obesity, MASH - BioPharma Dive
googlenews
Jan 4, 2024
Science/business updates
external-link
Omega Therapeutics To Participate In Two Upcoming Investor Conferences - Yahoo Finance
googlenews
May 30, 2024
Funding-related
external-link
Omega halts sole clinical-stage asset to focus on 3 programs
fiercebiotech.com
Dec 19, 2024
Science/business updates
external-link
Epigenetic modifications, or reversible modifications on top of #DNA or its scaffolding, control the winding of DNA’s 3D loops without altering underlying sequences. Our OMEGA platform leverages our u
linkedin
Nov 19, 2024
Science/business updates
external-link
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer
web
Dec 31, 2024
Science/business updates
external-link
Our goal was to create a platform that can precisely target and control gene expression, and we did just that.
The OMEGA platform has the potential to address a wide range of diseases, including some
linkedin
Nov 19, 2024
Science/business updates
external-link
Omega Therapeutics Announces Successful Completion of Phase - GlobeNewswire
googlenews
Nov 14, 2024
Science/business updates
external-link
Novo mRNA Obesity Deal Prompts Suit Against Omega Board, Backers - Bloomberg Law
googlenews
Jun 17, 2024
Funding-related
external-link
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors - Yahoo Finance
googlenews
Jun 24, 2024
New hires
external-link
Modulating Gene Expression to Stop Diseases in Their Tracks: a Pioneering Journey - BioSpace
googlenews
Mar 20, 2022
Science/business updates
external-link
Omega Therapeutics to Present Multiple Posters Highlighting - GlobeNewswire
googlenews
Oct 15, 2024
Science/business updates
external-link
Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial
crunchbase
Sep 26, 2023
Science/business updates
external-link
Flagship unveils 'genome-tuning' biotech Omega ...
fiercebiotech.com
Dec 19, 2024
Science/business updates
external-link
Omega Therapeutics to Advance Pipeline and Platform Development with $126 Million in Additional Financing - PR Newswire
googlenews
Mar 30, 2021
Funding-related
external-link
Compositions and methods for modulating forkhead box p3 (foxp3) gene expression
crunchbase
Sep 6, 2022
Science/business updates
external-link
Omega Therapeutics announces publication of preclinical data of OTX-2002
crunchbase
Sep 17, 2024
Science/business updates
external-link
Omega Therapeutics Appoints New Director Ravi Mehrotra - TipRanks
googlenews
Dec 6, 2024
New hires
external-link
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors - GlobeNewswire
googlenews
Jun 24, 2024
New hires
external-link
Gene Expression In Therapeutic R&D: Rick Young on The Long Run - Timmerman Report
googlenews
Jan 22, 2024
Science/business updates
external-link
Omega Therapeutics Stock: Starting 2024 With A Bang (NASDAQ:OMGA)
crunchbase
Jan 10, 2024
Science/business updates
external-link
Omega Therapeutics Announces First Patient Dosed in Landmark MYCHELANGELO™ I Trial of OTX-2002 in Hepatocellular Carcinoma and Other Solid Tumor Types Associated with the MYC Oncogene - PR Newswire
googlenews
Oct 27, 2022
Science/business updates
external-link
Epigenetic Technologies Find Clinical Applications - Genetic Engineering & Biotechnology News
googlenews
Apr 9, 2024
Science/business updates
external-link
Wishing all our #Omegans and their families a healthy, joyful, and peaceful holiday season! Thank you for your hard work, dedication, and passion throughout the year.
linkedin
Dec 24, 2024
None of the above
external-link
Omega, eyeing new uses for genome-tuning tech, taps ...
fiercebiotech.com
Dec 19, 2024
Science/business updates
external-link
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer - Yahoo Finance
googlenews
May 29, 2024
New hires
external-link
Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Tops Revenue Estimates
crunchbase
May 29, 2024
Science/business updates
external-link
We are driven by our mission to develop novel therapies to treat and potentially cure serious diseases using our OMEGA platform. This month at the 12th International #mRNAHealthConference and the Amer
linkedin
Nov 21, 2024
Science/business updates
external-link
Chutes & Ladders—Roche veteran James Sabry hangs up his hat - Fierce Biotech
googlenews
May 31, 2024
New hires
external-link
When Can We Expect A Profit From Omega Therapeutics, Inc. (NASDAQ:OMGA)? - Yahoo Finance
googlenews
Mar 3, 2023
Science/business updates
external-link
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update - GlobeNewswire
googlenews
Mar 28, 2024
Science/business updates
external-link
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
crunchbase
Aug 14, 2024
New hires
external-link
Novo Nordisk offers 2 Flagship biotechs up to $1B total for obesity, MASH deals - Fierce Biotech
googlenews
Jan 4, 2024
Funding-related
external-link
Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner
web
Dec 31, 2024
New hires
external-link
Omega Therapeutics (OMGA) Upgraded to Buy: Here's What You Should Know
crunchbase
Apr 3, 2024
Science/business updates
external-link
Epigenetic Editing Explodes on the Heels of Gene Editing Success - BioSpace
googlenews
Mar 21, 2024
Science/business updates
external-link
Omega Therapeutics stock more than doubles on Novo Nordisk obesity drug research pact - MarketWatch
googlenews
Jan 4, 2024
Funding-related
external-link
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers - Yahoo Finance
googlenews
May 8, 2024
Science/business updates
external-link
Omega Gets FDA Nod to Start First-Ever Epigenomic Controller Trial - BioSpace
googlenews
Jul 15, 2022
Science/business updates
external-link
Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models
web
Dec 31, 2024
Science/business updates
external-link
Omega Therapeutics, Inc. Announces Board and Committee Changes - Marketscreener.com
googlenews
Dec 12, 2024
New hires
external-link
Omega Therapeutics Submits IND For Liver Cancer Candidate
crunchbase
Jun 15, 2022
Science/business updates
external-link
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday - Benzinga
googlenews
Jan 4, 2024
Science/business updates
external-link
At #SITC2024, we presented a poster highlighting that controlled epigenomic upregulation of CXCL9 & CXCL10 in #HepatocellularCarcinoma promotes T-cell recruitment. These data exemplify the versatile c
linkedin
Nov 19, 2024
Science/business updates
external-link
Omega cuts 35% of workforce; Rhythm, CervoMed, Surrozen raise new funding - Endpoints News
googlenews
Apr 1, 2024
Funding-related
external-link
Omega Therapeutics Announces Pricing of Initial Public Offering - PR Newswire
googlenews
Jul 29, 2021
Funding-related
external-link
Omega Therapeutics presents new preclinical data at ASGCT 2024
crunchbase
May 8, 2024
Science/business updates
external-link
Omega halts sole clinical-stage program to prioritize Novo Nordisk collab and liver, obesity work - Fierce Biotech
googlenews
Nov 15, 2024
Science/business updates
external-link
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
crunchbase
Jul 1, 2024
New hires
external-link
Novo Nordisk enters into research collaborations with Omega - GlobeNewswire
googlenews
Jan 4, 2024
Science/business updates
external-link
After an obesity deal with Novo, Omega’s new business head is on the hunt for more partners - PharmaVoice
googlenews
Jun 24, 2024
Science/business updates
external-link
Omega Therapeutics Receives Orphan Drug Designation for OTX-2002 for the Treatment of Hepatocellular Carcinoma - PR Newswire
googlenews
Nov 2, 2022
Science/business updates
external-link
Novo Signs $1.1 Billion Obesity R&D Deals With Two Biotechs - Bloomberg
googlenews
Jan 4, 2024
Funding-related
external-link
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
crunchbase
Apr 17, 2024
Science/business updates
external-link
Omega Therapeutics: The Next Weight Loss Drug Runner (NASDAQ:OMGA)
crunchbase
Jan 16, 2024
Science/business updates
external-link
Omega Therapeutics announces board changes - Investing.com
googlenews
Dec 7, 2024
New hires
external-link
The 3 Best Biotech Stocks to Buy in January 2024
crunchbase
Jan 10, 2024
Science/business updates
external-link
Omega Therapeutics to Participate in Two Upcoming Investor Conferences
crunchbase
Sep 21, 2023
Funding-related
external-link
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual ...
crunchbase
Mar 6, 2024
Science/business updates
external-link
Currently available #obesity treatments focus on appetite management and may not be effective for every patient. At Omega, we are partnering with Novo Nordisk to potentially reimagine obesity treatmen
linkedin
Dec 12, 2024
Science/business updates
external-link
Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
googlenews
Apr 17, 2024
Science/business updates
external-link
Omega Therapeutics Appoints Chris Schade to its Board of Directors
crunchbase
Jul 12, 2023
New hires
external-link
Novo Nordisk announces two new research collaborations for cardiometabolic diseases - PMLiVE
googlenews
Jan 10, 2024
Science/business updates
external-link
Omega Therapeutics Announces Appointment of Joshua Reed as Chief Financial Officer
crunchbase
Apr 29, 2022
New hires
external-link
Omega Therapeutics Restructures Leadership and Strategic Focus - TipRanks
googlenews
Nov 14, 2024
New hires
external-link
Omega Therapeutics Announces Appointment of Yan Moore, M.D., as Chief Medical Officer
crunchbase
Jan 10, 2022
New hires
external-link
Today we announced our Third Quarter 2024 financial results, completion of our Phase 1 study and strategic updates. Learn more in our press release: https://bit.ly/3URA77S
linkedin
Nov 19, 2024
Science/business updates
external-link
Omega Therapeutics' epigenomic medicines reduce MYC expression by 55% in early study of cancer patients - Endpoints News
googlenews
Sep 26, 2023
Science/business updates
external-link
Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress - Yahoo Finance
googlenews
Aug 6, 2024
Science/business updates
external-link
Novo Nordisk ties up with Metaphore to develop new obesity drugs - Reuters.com
googlenews
May 9, 2024
Science/business updates
external-link
Omega Therapeutics Unveils New Epigenomic Controller Development Candidate Targeting MYC-Driven Non-Small Cell Lung Cancer - PR Newswire
googlenews
Oct 12, 2022
Science/business updates
external-link
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
crunchbase
May 29, 2024
Science/business updates
external-link
© 2025 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com